| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2020 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 2,191 | $163.43 | $358,075.13 | -100% | |
| Feb 20, 2020 | DHR Danaher Corp /de/ | King William | SVP, Strategic Development | Sell | 26,370 | $160.23 | $4,225,191.01 | -17.6% | |
| Feb 20, 2020 | NOTV Inotiv, Inc. | Johnson Richard Allen | Director | Buy | 20,000 | $4.63 | $92,600.00 | +200.0% | |
| Feb 20, 2020 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Buy | 9,458 | $4.60 | $43,506.80 | +46.0% | |
| Feb 19, 2020 | CSTL Castle Biosciences Inc | Sofinnova Healthquest Partners, L.P. | 10% Owner | Sell | 25,000 | $32.03 | $800,750.00 | -1.5% | |
| Feb 19, 2020 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 5,688 | $165.09 | $939,031.92 | -72.2% | |
| Feb 19, 2020 | CSTL Castle Biosciences Inc | Kabakoff David S74 | Director, 10% Owner | Sell | 25,000 | $32.03 | $800,750.00 | -1.5% | |
| Feb 19, 2020 | EXAS Exact Sciences Corp | Cole G Bradley | General Manager - Diagnostics | Sell | 27,356 | $100.00 | $2,735,600.00 | -72.9% | |
| Feb 19, 2020 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, New Ventures | Sell | 1,153 | $100.68 | $116,084.04 | -31.6% | |
| Feb 18, 2020 | IQV Iqvia Holdings Inc. | Staub W Richard | See Remarks | Sell | 14,550 | $163.77 | $2,382,853.50 | -40.5% | |
| Feb 18, 2020 | CRL Charles River Laboratories International, Inc. | Milne George M Jr59 | Director | Sell | 7,170 | $176.07 | $1,262,429.79 | -21.0% | |
| Feb 18, 2020 | CDNA Caredx, Inc. | Maag Peter83 | Chief Executive Officer | Sell | 10,000 | $26.62 | $266,201.00 | -2.2% | |
| Feb 14, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.57 | $157,291.44 | - | |
| Feb 14, 2020 | CDNA Caredx, Inc. | King Sasha77 | Chief Commercial Officer | Sell | 7,390 | $26.01 | $192,220.55 | -13.2% | |
| Feb 14, 2020 | CRL Charles River Laboratories International, Inc. | Wallman Richard F81 | Director | Sell | 3,530 | $174.29 | $615,257.82 | -10.7% | |
| Feb 14, 2020 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 1,358 | $773.74 | $1,050,735.86 | -11.7% | |
| Feb 14, 2020 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 24,216 | $768.04 | $18,598,746.21 | -8.1% | |
| Feb 13, 2020 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 2,000 | $82.02 | $164,040.00 | -60.6% | |
| Feb 13, 2020 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 900 | $172.05 | $154,845.00 | -3.7% | |
| Feb 13, 2020 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 15,000 | $171.90 | $2,578,439.64 | -2.5% | |
| Feb 13, 2020 | CRL Charles River Laboratories International, Inc. | Wallman Richard F81 | Director | Sell | 7,170 | $172.02 | $1,233,391.29 | -19.6% | |
| Feb 13, 2020 | IQV Iqvia Holdings Inc. | Connaughton John | Director | Sell | 703,828 | $164.30 | $115,638,940.40 | -50.7% | |
| Feb 13, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.58 | $158,000.00 | - | |
| Feb 13, 2020 | CRL Charles River Laboratories International, Inc. | Bertolini Robert J | Director | Sell | 7,170 | $170.41 | $1,221,818.91 | -20.5% | |
| Feb 13, 2020 | IQV Iqvia Holdings Inc. | Tpg Group Holdings (sbs) Advisors, Inc.86 | Director | Sell | 2,996,172 | $164.30 | $492,271,059.60 | -50.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.